• ECL Western Blotting Substrate: Technical Application Guide

  2026-06-30

  ECL Western Blotting Substrate (SKU K2187) is designed for sensitive, nonradioactive chemiluminescent detection of HRP-conjugated proteins in Western blot assays. It enables clear signal visualization and supports repeated probing, making it suitable for workflows in molecular biology, cancer biology, and signal transduction pathway research. This product should not be used for fluorescent or radioisotopic detection methods.

• Inhibiting Extracellular Vesicle Release in Triple-Negative

  2026-06-30

  McNamee et al. conducted a comprehensive study identifying effective chemical inhibitors of extracellular vesicle (EV) release in triple-negative breast cancer (TNBC) cells. Their findings demonstrate that broadly targeting EV secretion—using agents including the calpain inhibitor Calpeptin—can substantially limit the transmission of aggressive cancer traits, informing both cancer biology and the design of EV-modulation protocols.

• Ibuprofen as an Anti-Proliferative Agent: Protocols & Optimi

  2026-06-29

  Leveraging Ibuprofen’s dual COX-inhibition and apoptosis-inducing effects unlocks new frontiers in colon cancer research. This guide delivers actionable protocols, advanced troubleshooting, and cross-study insights to maximize reproducibility and scientific impact.

• GPX4-Driven Glutathione Consumption Promotes Platinum Resist

  2026-06-29

  This study reveals that acquired platinum chemoresistance in lung cancer-derived brain metastases is driven by a high-consumption state of glutathione (GSH) regulated through GPX4 and GSTM1, and transcriptionally upregulated via Wnt/NR2F2 signaling. These findings identify a key axis suppressing ferroptosis and offer mechanistic insights for overcoming drug resistance in metastatic lung cancer.

• N3-kethoxal (SKU A8793): Data-Driven Solutions for Nucleic A

  2026-06-28

  This article explores how N3-kethoxal (SKU A8793) addresses real laboratory challenges in nucleic acid structure analysis, RNA–protein interaction mapping, and genomic accessibility profiling. Scenario-based Q&A blocks provide evidence-backed guidance for optimizing assay reproducibility, sensitivity, and workflow integration using this azide-functionalized, membrane-permeable probe.

• 2-NBDG for Glucose Uptake: Advanced Workflows and Troublesho

  2026-06-27

  2-NBDG, a fluorescent glucose analog, unlocks real-time quantification of cellular glucose uptake in diverse models. This article delivers actionable protocols, troubleshooting strategies, and insights from cutting-edge glioblastoma research—empowering scientists to maximize the reliability and interpretive power of their glucose metabolism assays.

• Luminescent ATP Detection Assay Kit: Precision in Apoptosis

  2026-06-26

  Unlock ultra-sensitive, reproducible ATP measurement in cell and tissue models with the Luminescent ATP Detection Assay Kit. This firefly luciferase ATP assay streamlines apoptosis and metabolic profiling, offering robust linearity and compatibility for downstream workflows.

• Wnt/NR2F2 Signaling Drives Platinum Resistance in Lung Cance

  2026-06-26

  This study reveals that glutathione peroxidase 4 (GPX4)-dependent high glutathione consumption underlies acquired platinum resistance in lung cancer brain metastases, driven by transcriptional upregulation via a Wnt/NR2F2 pathway. These findings clarify a mechanistic link between canonical Wnt signaling and chemoresistance, offering new targets for therapeutic intervention.

• Advancing mRNA Rescue: Mechanisms and Strategy for FLCN in B

  2026-06-25

  This thought-leadership article explores how high-yield in vitro RNA synthesis platforms, exemplified by the HyperScribe™ T7 High Yield RNA Synthesis Kit Plus, are enabling a new era of mRNA-based therapeutic strategies for rare genetic disorders. Using recent mechanistic and translational evidence around FLCN mRNA rescue in Birt-Hogg-Dubé syndrome, we provide both the biological rationale and practical protocol parameters for researchers aiming to bridge discovery and intervention. We contextualize these findings in the evolving competitive landscape, cross-link to emerging literature, and offer a strategic outlook for translational teams navigating the mRNA therapeutic pipeline.

• PGF2α/PTGFR and HIF-1α in Endometrial Breakdown Dynamics

  2026-06-25

  This study illuminates how prostaglandin F2α signaling through its receptor (PTGFR), under HIF-1α regulation, orchestrates endometrial breakdown and vascular remodeling in a mouse menstrual-like model. Pharmacological inhibition of PTGFR—using selective antagonists such as AL-8810—demonstrated that PGF2α-driven pathways are essential for tissue shedding and vascular changes, offering a refined mechanistic understanding with practical implications for reproductive biology research.

• Pexmetinib (ARRY-614): Mechanistic Advances in Dual Pathway

  2026-06-24

  Explore how Pexmetinib (ARRY-614) from APExBIO is redefining strategies for translational researchers targeting inflammatory signaling and myelodysplastic syndromes with dual inhibition of p38 MAPK and Tie2. This article blends deep mechanistic insights with practical recommendations, highlighting recent breakthroughs in conformational kinase regulation and protocol design.

• Weight Loss Restores Intestinal Stretch-Mediated Satiety in

  2026-06-23

  This study demonstrates that obesity impairs the ability of intestinal stretch to acutely suppress food intake and improve glucose tolerance, but these regulatory responses are restored by both dietary and surgical weight loss. The findings reveal that intestinal stretch mediates satiety and metabolic effects independently of classical incretin signaling, challenging prior assumptions about gut hormone dependence and informing future metabolic research.

• Genotyping Kit for Target Alleles: Streamlined DNA Prep for

  2026-06-23

  The Genotyping Kit for target alleles of insects, tissues, fishes and cells accelerates genomic DNA preparation by eliminating labor-intensive extraction steps. Its single-tube, phenol-free protocol reduces contamination risk while delivering robust PCR results, making it invaluable for high-throughput genetic analysis in research settings.

• Defined Culture Environments Advance Human Intestinal Organo

  2026-06-22

  Capeling's dissertation demonstrates that precisely defined culture conditions, including GSK-3 inhibition, enable more reproducible and physiologically relevant human intestinal organoids (HIOs) from pluripotent stem cells. The study's protocols facilitate robust modeling of intestinal development and disease, with practical value for translational and basic research.

• Sinapine Disrupts Gαq-PLCβ3 Axis to Mitigate Cardiovascular

  2026-06-22

  This study identifies sinapine as a targeted inhibitor of the Gαq-PLCβ3 signaling axis, demonstrating its ability to alleviate cardiovascular disease in animal models by binding specifically to the PLCβ3 EF hands domain. The findings highlight a more selective approach to modulating RAAS-driven pathologies with reduced side effects compared to traditional Gαq inhibitors.

16429 records 1/1096 page Next 12345 下5页 Last page